FDA sets review date for SpinalMotion's artificial disc

05/8/2013 | MassDevice.com (Boston)

An FDA panel will meet on July 24 to evaluate SpinalMotion's premarket approval application for the Kineflex/C system. The metal-on-metal total disc replacement device, which is already available in Europe, is intended for one-level repair of the intervertebral disc in patients who have undergone single-level discectomy for lumbar degenerative disc disease.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA